Learning Personalized Treatment Strategies with Predictive and Prognostic Covariates in Adaptive Clinical Trials

• 成果类型: Article
• 署名作者: Alban, Andres; Chick, Stephen E.; Zoumpoulis, Spyros I.
• 署名单位: Frankfurt School Finance & Management; INSEAD Business School; INSEAD Business School
• 刊物名称: MANAGEMENT SCIENCE
• ISSN/ISSBN: 0025-1909
• DOI: 10.1287/mnsc.2022.02048
• 发表日期: 2026
• 关键词: adaptive clinical trial design; contextual bandit; sequential learning; Bayesian optimization; expected value of information; sepsis

摘要

Biomedical research may uncover insights regarding the interaction of the treatments of a disease with patient covariates. We show how to use such insights to improve the efficiency of adaptive clinical trials for precision medicine by extending ideas from optimal Bayesian learning. We present a model for response-adaptive multi-arm clinical trials that leverages knowledge about the predictive-prognostic covariate structure to accelerate the learning of personalized treatment strategies that obtain the best expected outcomes for post-trial patients. Our base model is a contextual linear bandit for best-arm identification, and outcomes may be observed with delay. We characterize the optimal policy for sequentially allocating treatments to in-trial patients and, because it is hard to compute, propose several computable heuristics based on Bayesian one-step look-ahead techniques. We prove that several of our proposed heuristics are asymptotically optimal in learning treatment strategies. Numerical results based on two case studies motivated by sepsis management show that our heuristics can significantly improve clinical trial efficiency to learn a treatment strategy for precision medicine. We provide extensions that allow for rewards from outcomes of in-trial patients (resolving the exploration-exploitation tradeoff) and for inferring covariate structure using Lasso when biomedical insights on covariate structure are lacking. Our proposed trial design is of interest to funders, designers, and managers of clinical trials. It may also apply to other contextual bandit problems in settings where insights about covariate-treatment interactions are available.